Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,157 | 21,392 | 24,575 | 15,233 | 20,618 |
| Marketable Securities | 58,930 | 92,006 | 107,033 | 129,290 | 145,535 |
| TOTAL | $93,637 | $120,676 | $140,937 | $152,962 | $174,324 |
| Non-Current Assets | |||||
| PPE Net | 608 | 784 | 945 | 1,128 | 1,316 |
| Investments And Advances | 0 | 0 | 311 | 311 | 311 |
| Other Non-Current Assets | 919 | 1,722 | 1,168 | 1,311 | 992 |
| TOTAL | $1,527 | $2,506 | $2,424 | $2,750 | $2,619 |
| Total Assets | $95,164 | $123,182 | $143,361 | $155,712 | $176,943 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 25,700 | 14,502 | 3,578 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,670 | 2,530 | 2,210 | 3,527 | 2,166 |
| Accrued Expenses | 12,742 | 15,953 | 11,571 | 11,055 | 9,306 |
| TOTAL | $42,781 | $33,898 | $18,344 | $15,541 | $12,406 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,585 | 31,458 | 42,065 | 45,332 | 45,032 |
| Other Non-Current Liabilities | 0 | 0 | 164 | 419 | 669 |
| TOTAL | $20,585 | $31,458 | $42,229 | $45,751 | $45,701 |
| Total Liabilities | $63,366 | $65,356 | $60,573 | $61,292 | $58,107 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,562 | 64,240 | 64,240 | 62,734 | 61,856 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -415,993 | -387,954 | -360,880 | -336,310 | -309,277 |
| Other shareholders' equity | -5 | 69 | 186 | -103 | -105 |
| TOTAL | $31,798 | $57,826 | $82,788 | $94,420 | $118,836 |
| Total Liabilities And Equity | $95,164 | $123,182 | $143,361 | $155,712 | $176,943 |